ABIONYX Pharma Provides an Update on Its Activity and Cash Position for the 1 st Quarter 2025
ABIONYX Pharma (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies based on the world's only natural recombinant apoA-I, today provides an update on its activity and cash position as of March 31, 2025.
Selected financial information (IFRS)
ABIONYX Pharma recorded consolidated quarterly sales of nearly €1 million in Q1 2025, down on Q1 2024. This decline is cyclical and reflects a wait-and-see attitude on the part of customers in the context of uncertain US customs policy. In the business dedicated to the discovery and development of innovative therapies designed to improve patients' lives, the Company generated no sales in the quarter, as ABIONYX Pharma continues to provide its bioproduct free of charge in the context of compassionate access applications.
As at March 31, 2025, the Company had cash and cash equivalents of nearly €4.1 million, before receipt of the estimated €1.08 million Research Tax Credit and after receipt of the first €2.17 million tranche of France 2030 funding.
R&D update and anticipated key milestones:
Concerning the rare disease known as 'LCAT Deficiency' (Lecithin Cholesterol Acyl-Transferase deficiency or Norum disease), the Company continues to receive new requests for Compassionate Access Authorization (CAA) for recombinant apoA-I, CER-001, from several hospitals around the world. Last May, ABIONYX Pharma sent the European Medicines Agency (EMA) the clinical results of treated patients, with a view to continuing discussions and obtaining feedback for a future application for Compassionate Access.
With regard to sepsis, ABIONYX Pharma is pursuing its strategic plan to find a strategic partner for its biomedicine.
About ABIONYX Pharma
ABIONYX Pharma is a next-generation biotech company focused on developing innovative medicines for diseases where there is no effective or existing treatment, even the rarest ones. The company expedites the development of novel therapeutics through an extensive expertise in lipid science and a differentiated apoA-I-based technology platform. ABIONYX Pharma is committed to radically improving treatment outcomes in Sepsis and critical care.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
a few seconds ago
- Business Wire
Delta Capita Acquires DTCC's Report Hub to expand Pre- and Post-Trade Reporting Solutions
LONDON--(BUSINESS WIRE)-- Delta Capita, a leading global capital markets managed services, technology and consulting provider, has acquired the Report Hub pre- and post-trade reporting solution from The Depository Trust & Clearing Corporation (DTCC), adding to its growing portfolio of solutions for OTC Derivatives and Securities Operations. Report Hub provides a highly efficient solution for pre- and post-trade reporting, helping firms manage the complexities of global regulatory reporting mandates in eight global jurisdictions and 14 regulatory regimes, including EMIR, MiFID, SFTR, MAS, ASIC and CFTC. This acquisition extends Delta Capita's client base to nearly 250 institutional clients globally including banks, hedge funds assets managers across Europe, APAC and North America and accelerates Delta Capita's vision to deliver managed services and technology in complex operational areas across the financial services industry. Joe Channer, CEO at Delta Capita, commented: 'Through further investment and innovation we expect Report Hub to become the industry's first choice for multi-jurisdictional pre-reporting and post-reporting obligations. Combined with our regulatory operations and advisory capabilities, Delta Capita now offers a complete range of services to support clients regulatory reporting, accelerating our strategy for delivering mutualised managed services across the capital markets value chain.' Mark Aldous, Global Head of Capital Markets Managed Services at Delta Capita, stated: 'The acquisition of the industry's leading pre- and post-trade reporting tool complements our deep expertise in trade reporting, enabling us to meet our clients' requirements across technology and managed services to advisory and regulatory reporting operations. Report Hub complements Delta Capita's existing range of specialist managed services and technologies across derivatives and structured products, post-trade, market infrastructure, pricing and risk, and KYC services.' This milestone builds on Delta Capita's recent successes, including strategic acquisitions and advancements in capital markets technology. It further solidifies Delta Capita's role as a trusted partner to global financial institutions seeking scalable, efficient solutions in an ever-evolving market, and follows HSBC's selection of Delta Capita to deliver OTC derivatives confirmation and settlement services globally under a multi-year agreement announced earlier this year. Find out more about Delta Capita's regulatory reporting offering here: About Delta Capita Delta Capita is a leading global capital markets managed services, technology and consulting provider. With a team of over 1,500 professionals across Europe, Asia, and the Americas, Delta Capita specialises in delivering multi-client managed services by integrating advanced technology, skilled talent, and robust infrastructure.
Business Wire
31 minutes ago
- Business Wire
Ryan Acquires LHL Property Auditors Ltd
LONDON & DALLAS--(BUSINESS WIRE)-- Ryan, a leading global tax services and software provider, has announced the acquisition of LHL Property Auditors Ltd (LHL), a boutique property tax firm based in the UK focused on recovery of business rates reliefs and exemptions. Founded in 2014, LHL brings more than 50 years of combined experience in business rates legislation, valuation, and compliance. With deep expertise in business rates legislation and local authority processes, the firm serves as a trusted adviser to clients across the industrial, retail, and office sectors. LHL applies a proven audit methodology to ensure accurate assessments and eliminate overpayments, focusing on local authority billing reviews, relief entitlement evaluations, rateable value analysis, and exemption qualification. 'As deeply qualified experts in business rates legislation and compliance, LHL offers our property tax clients immense value in identifying greater opportunities to leverage available tax relief,' said Ryan President of European and Asia-Pacific Operations Tom Shave. 'This acquisition aligns with our Firm's mission to ensure taxpayers pay only what they owe by identifying compliant, customised solutions, and we look forward to bolstering our consulting offering to our UK clients.' Through this acquisition, Ryan welcomes 25 new team members, including LHL founder Paul Hegarty who joins the Firm as a Director. The acquisition also establishes a new Ryan office in Chippenham, further expanding the Firm's UK footprint. 'Joining a global Firm that is well aligned to our strategic goal of identifying opportunities to recover taxpayer overpayments will be hugely beneficial to our clients,' said Hegarty. 'Merging our expertise will empower further success thanks to the winning blend of customised services and unmatched technology that fuels results.' About Ryan Ryan, an award-winning global tax services and software provider, is the largest Firm in the world dedicated exclusively to business taxes. The Firm provides an integrated suite of international tax services on a multijurisdictional basis, including cost management, compliance, consulting, technology and transformation, and innovation funding. Ryan is an 11-time recipient of the International Service Excellence Award from the Customer Service Institute of America (CSIA) for its commitment to world-class client service. Empowered by the dynamic myRyan work environment, which is widely recognised as the most innovative in the tax services industry, Ryan's multidisciplinary team of more than 5,900 professionals and associates serves over 77,000 clients in more than 80 countries, including many of the world's most prominent Global 5000 companies. More information about Ryan can be found at
Business Wire
31 minutes ago
- Business Wire
Oxmiq Labs Inc.™: Re-Architecting the GPU Stack: From Atoms to Agents™
CAMPBELL, Calif.--(BUSINESS WIRE)-- Oxmiq Labs Inc., the all-new GPU software and IP startup founded by one of the world's top GPU architects and visionaries, Raja Koduri, emerges from stealth after two years of intensive IP development. Raja has assembled a world-class team of GPU and AI architects with over 500 years of combined experience, hundreds of patents, and a collective track record of generating more than $100B in revenue at prior companies. The Opportunity: Modern computing has fundamentally shifted toward multimodal experiences where text, audio, video, images, and 3D environments seamlessly interact, establishing GPU architecture as the cornerstone of this transformation. Unlike fixed-function AI accelerators that handle specific tasks, GPUs provide the general-purpose computational flexibility required for these diverse modalities while maintaining deep integration with mainstream operating systems through standardized APIs and unified memory models. This architectural advantage positions GPUs as the essential compute engine for both current applications and the emerging landscape of multimodal AI, where heterogeneous workloads must be processed in harmony. OXMIQ™'s licensable GPU IP rearchitects the GPU from first principles incorporating breakthrough technologies including nano agents in silicon leveraging RISC-V cores, near-memory and in-memory computing, and light transport. OXMIQ delivers solutions that balance multimodal computing flexibility with the radical performance improvements required for next-generation graphics and AI workloads for its customers. Software First: Learning from decades of industry evolution, OXMIQ embraces a Software First strategy that prioritizes developer experience through a comprehensive software stack compatible with bothOXMIQ IP-based silicon and third-party GPU and AI accelerator platforms. OXCapsule™, OXMIQ's unified software ecosystem, abstracts away hardware complexity to provide frictionless deployment across diverse computing platforms, eliminating the configuration challenges that traditionally plague heterogeneous environments. A flagship component, OXPython™, enables Python-based NVIDIA® CUDA™ AI applications to execute seamlessly on non-NVIDIA hardware without code modification or recompilation. Launching initially on Tenstorrent's AI platform later this year with multiple vendor integrations in progress, OXPython demonstrates OXMIQ's commitment to breaking down hardware silos and accelerating the democratization of high-performance computing across the industry. 'We're excited to partner with OXMIQ on their OXPython software stack,' said Jim Keller, CEO of Tenstorrent™. 'OXPython's ability to bring Python® workloads for CUDA to AI platforms like Wormhole™ and Blackhole™ is great for developer portability and ecosystem expansion. It aligns with our goal of letting developers open and own their entire AI stack.' The OXMIQ Breakthrough: Beyond software, OXMIQ delivers a complete GPU hardware IP stack that powers silicon solutions scaling from Physical AI in edge devices and autonomous robots to enterprise edge infrastructure and zettascale data centers. Their scalable GPU core, OXCORE™, integrates scalar, vector, and tensor compute engines in a modular architecture customizable for specific workloads, enabling nano-agents, native Python acceleration, and compatibility with SIMD/CUDA paradigms. OXCORE scales seamlessly from single core for compact Physical AI applications to thousands of cores for data centers via the OXQUILT™ chip-let architecture. Through OXQUILT, customers can configure optimal ratios of compute, memory and interconnect for their needs and achieve significant reduction in time to market, R&D and production costs v/s current industry standard methodologies. Capital Efficiency & Market Traction: OXMIQ has raised $20 million in seed funding from prominent technology investors, including strategic players in mobile and AI silicon such as MediaTek®, and has recorded its first round of software revenue. With its licensing-first model, OXMIQ avoids the heavy capital requirements of chip startups that depend on expensive EDA tools and physical tape-outs — delivering outstanding capital efficiency. 'OXMIQ has an impressive bold vision and world-class team,' said Lawrence Loh, SVP of MediaTek 'The company's GPU IP and software innovations will drive a new era of compute flexibility across devices – from mobile to automotive to AI on the edge.' Mihira™: After co-founding Mihira two years ago with Shobu Yarlagadda and SS Rajamouli, Raja Koduri has transitioned out of day-to-day operations at Mihira to focus full-time on running OXMIQ. Raja now acts as a strategic advisor to Mihira Visual Labs™, which is led by CEO Shobu Yarlagadda. OXMIQ holds a minority stake in Mihira and will continue to support its growth through foundational agentic and GPU IP technologies that power Mihira's cinematic AI platform. 'Raja's early contributions to Mihira helped shape our foundational vision of cinematic AI. Now, with OXMIQ, he and his team are building the deep-tech infrastructure that powers our next chapter,' said Shobu Yarlagadda, Co-Founder and CEO of Mihira Visual Labs™, and acclaimed producer of the Baahubali film series. 'As we scale Mihira into a global creative platform, we're thrilled to continue our close collaboration with OXMIQ and integrate their agentic GPU innovations into our storytelling stack.' To learn more about licensing, investment, or career opportunities visit us on the web at NVIDIA and CUDA are trademarks or registered trademarks of NVIDIA Corporation in the U.S. and other countries. Python is a registered trademark of the Python Software Foundation. Tenstorrent, Wormhole, and Blackhole are trademarks of Tenstorrent Inc. MediaTek is a registered trademark of MediaTek Inc. All other product names, trademarks, and registered trademarks are property of their respective owners and are used for identification purposes only.
